Sort
35,931 grants matching “parkinsons”
Neuro Therapeutics Research Institute (1 of 6)
$782,853Paul J Hagerman · University Of California At Davis · UL1 · FY2008 · DE
Development of a Nanoparticle-Based Gene Editing Technology for Neurological Applications
$782,842Krystof S Bankiewicz · Ohio State University · UG3 · FY2021 · NS
Controlled Trial of DBS for OCD
$782,620Benjamin D Greenberg · Butler Hospital (Providence, Ri) · U01 · FY2007 · MH
Development of a nanoparticle-based gene editing technology for neurological applications
$782,572Krystof S Bankiewicz · Ohio State University · UG3 · FY2020 · NS
Focused Ultrasound-mediated Delivery of Gene-editing Elements to the Brain for Neurodegenerative Disorders
$782,568Kam W Leong · Columbia University Health Sciences · UG3 · FY2020 · NS
Modeling functional genomics of susceptibility to the persistent effects of environmental toxins in an elderly rural Indiana neurodegenerative cohort
$782,373Aaron B Bowman · Purdue University · R01 · FY2022 · AG
Structural Dynamics of Cardiac Muscle Calcium ATPase Regulation
$782,326David Dale Thomas · University Of Minnesota · R01 · FY2020 · HL
Core B - Clinical Core
$782,117Teresa Gomez-Isla · Massachusetts General Hospital · P50 · FY2018 · AG
Earlier vs. Later Levodopa in Parkinson's Disease
$782,085Columbia University Health Sciences · R01 · FY2002 · NS
Genome wide SNP analysis in Parkinson's disease
$782,025Andrew Singleton · National Institute On Aging · ZIA · FY2012 · AG
Core B - Clinical Core
$781,779Teresa Gomez-Isla · Massachusetts General Hospital · P50 · FY2016 · AG
Core B - Clinical Core
$781,779Teresa Gomez-Isla · Massachusetts General Hospital · P50 · FY2014 · AG
A futility trial of sirolimus in multiple system atrophy
$781,753Horacio Kaufmann · New York University School Of Medicine · R01 · FY2020 · NS
Neuroprotective And Neurorestorative Signaling Mechanisms
$781,688Mark P Mattson · Aging · Z01 · FY2007 · AG
Design And Development Of Experimental Therapeutics
$781,688Nigel H. Greig · Aging · Z01 · FY2007 · AG
Neural control of breathing
$781,655Jack L. Feldman · University Of California Los Angeles · R35 · FY2021 · HL
Neural control of breathing
$781,655Jack L. Feldman · University Of California Los Angeles · R35 · FY2017 · HL
Neural control of breathing
$781,655Jack L. Feldman · University Of California Los Angeles · R35 · FY2022 · HL
Neural control of breathing
$781,655Jack L. Feldman · University Of California Los Angeles · R35 · FY2023 · HL
Neural control of breathing
$781,655Jack L. Feldman · University Of California Los Angeles · R35 · FY2019 · HL
Neural control of breathing
$781,655Jack L. Feldman · University Of California Los Angeles · R35 · FY2020 · HL
Neural control of breathing
$781,655Jack L. Feldman · University Of California Los Angeles · R35 · FY2018 · HL
The impact of early Tau pathology on cognitive progression and neuropsychiatric symptoms in Parkinson's disease
$781,525Kathleen Lombard Poston · Stanford University · R01 · FY2019 · NS
Mechanisms of Prion Protein Toxicity
$781,315David A Harris · Boston University Medical Campus · R01 · FY2024 · NS
Project 3: Effect of Age and Longevity Genes on Epigenomic Mechanisms
$780,905Joseph C Wu · Stanford University · P01 · FY2015 · GM